Pharmaceutical factory that manufactures hydroxychloroquine mysteriously bursts into flames, explodes
On Dec. 20, an SCI Pharmtech manufacturing facility in Taoyuan City, Taiwan, burst into flames and exploded, leaving two people injured.
The facility, which manufactures the anti-Wuhan coronavirus (COVID-19) drug hydroxychloroquine, appears to have been targeted, perhaps by COVID-19 vaccine interests, in an effort to punish the company for manufacturing the inexpensive, highly effective remedy for the novel virus.
People as far away as New Taipei City, located in Taiwan’s Tamsui District, reported hearing a large blast shortly after noon on Sunday. Immediately following the blast, thick black smoke was seen pouring out of the SCI Pharmtech factory.
A 30-year-old foreign migrant worker suffered third-degree burns to about 90 percent of his body, and is now in critical condition. A 40-year-old man suffered similar burns but only on his hand. Both men were rushed to Chang Gung Memorial Hospital for treatment.
The SCI Pharmtech factory in question is the second-largest HCQ provider in Asia. It has since been closed, meaning no more HCQ production for the time being. The nearby Taipei Taoyuan International Airport, however, remains open for travel despite being in close proximity to the deadly blast.
Authorities are still investigating the cause of the explosion, which is all too convenient having occurred just days after Big Vaccine started publicly releasing COVID-19 jabs as the alleged “cure” for the plandemic.